In a recent interview with Swedish healthcare publication Dagens Medicin, Nelly Fransén, Expert Regulatory Affairs and specialist in pharmaceutical formulation, discussed the practical and regulatory considerations involved in producing pharmacy-compounded alternatives to transdermal oestrogen medicines in Sweden. In this article, she shares further insights into the complexity of solving medicine shortages.
Linnea Brodin
Finance Manager
BSc Business and Economics
Linnea is our Finance Manager. She has a BSc in Business and Economics from Södertörns University and has previously worked in the accounts payable department at Huddinge Kommun.
Staffan Thunell
Founding partner
BSc Economics and BA
Staffan has a long background in entrepreneurship within the life science industry. He has 20+ years experience from positions as Founder, Chairman, CEO and CFO within medical affairs consulting and small pharma. Previously Staffan worked in executive positions in big pharma and specialty pharma companies.